It has been noted that patients with SLE, including those with new-onset disease, display increased serum or plasma levels of IL-17A, have an expansion of IL-17-producing T cells in the peripheral blood, and an infiltration of Th17 cells in the target organs, including the kidneys34, 35. Here, IL17A is linked to systemic lupus erythematosus.